1. Home
  2. BIAF vs BBGI Comparison

BIAF vs BBGI Comparison

Compare BIAF & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • BBGI
  • Stock Information
  • Founded
  • BIAF 2014
  • BBGI 1961
  • Country
  • BIAF United States
  • BBGI United States
  • Employees
  • BIAF N/A
  • BBGI N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BBGI Broadcasting
  • Sector
  • BIAF Health Care
  • BBGI Consumer Discretionary
  • Exchange
  • BIAF Nasdaq
  • BBGI Nasdaq
  • Market Cap
  • BIAF 14.5M
  • BBGI 13.2M
  • IPO Year
  • BIAF 2022
  • BBGI 2000
  • Fundamental
  • Price
  • BIAF $0.67
  • BBGI $8.40
  • Analyst Decision
  • BIAF Strong Buy
  • BBGI
  • Analyst Count
  • BIAF 1
  • BBGI 0
  • Target Price
  • BIAF $6.00
  • BBGI N/A
  • AVG Volume (30 Days)
  • BIAF 298.9K
  • BBGI 8.1K
  • Earning Date
  • BIAF 11-14-2024
  • BBGI 02-10-2025
  • Dividend Yield
  • BIAF N/A
  • BBGI N/A
  • EPS Growth
  • BIAF N/A
  • BBGI N/A
  • EPS
  • BIAF N/A
  • BBGI 1.69
  • Revenue
  • BIAF $9,367,785.00
  • BBGI $238,754,777.00
  • Revenue This Year
  • BIAF $285.51
  • BBGI $2.55
  • Revenue Next Year
  • BIAF $20.05
  • BBGI N/A
  • P/E Ratio
  • BIAF N/A
  • BBGI $5.07
  • Revenue Growth
  • BIAF 2813.87
  • BBGI N/A
  • 52 Week Low
  • BIAF $0.64
  • BBGI $7.60
  • 52 Week High
  • BIAF $3.62
  • BBGI $18.80
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 26.36
  • BBGI 43.22
  • Support Level
  • BIAF $0.64
  • BBGI $8.20
  • Resistance Level
  • BIAF $1.01
  • BBGI $9.46
  • Average True Range (ATR)
  • BIAF 0.07
  • BBGI 0.46
  • MACD
  • BIAF -0.01
  • BBGI -0.07
  • Stochastic Oscillator
  • BIAF 5.99
  • BBGI 13.16

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.

Share on Social Networks: